In general, the human cervix carcinoma HeLa cells were more sensitive to both these two series of compounds as compared with the other four cell lines, with derivatives 6g and 11a being 10-fold more potent than CA-4, while compounds 6a, 6c, and 6f had nearly equivalent activity to CA-4. The gene discussed is CA4; the disease is cervical carcinoma.